Stay updated with breaking news from Receive Positive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
At the end of the latest market close, BioNTech SE (BNTX) was valued at $118.43. In that particular session, Stock kicked-off at the price of $122.00 while reaching the peak value of $131.85 and lowest value recorded on the day was $121.14. The stock current value is $131.64.Recently in News on Octo
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union